| Description | Axillaridine A is a new cholinesterase inhibitors, it may act as potential leads in the discovery of clinically useful inhibitors for nervous-system disorders, particularly by reducing memory deficiency in Alzheimer's disease patients by potentiating and effecting the cholinergic transmission process. (+)-Axillaridine A has significant activity as antiestrogen binding site (AEBS)-inhibitory agents. |
| molecular weight | 462.67 |
| Molecular formula | C30H42N2O2 |
| CAS | 128255-16-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |